Arixtra

Active Ingredient(s): Fondaparinux
FDA Approved: * December 7, 2001
Pharm Company: * GLAXOSMITHKLINE
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Arixtra Overview

Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories. Contents 1 Medical uses 1.1 Administration 1.2 Comparison to other agents 2 Pharmacology 2.1 Mechanism of action 3 Chemistry 3.1 Abbreviations 4 References 5 External links Medical uses Clinically, it is used for the prevention of ...

Read more Arixtra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fondaparinux

Recent Arixtra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fondaparinux
  • Injection: 10mg/0.8ml, 2.5mg/0.5ml, 5mg/0.4ml, 7.5mg/0.6ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arixtra: (9 results)

Sorted by National Drug Code
  • 0007-3230 Arixtra 2.5 mg/.5ml Subcutaneous Injection, Solution by Glaxosmithkline LLC
  • 0007-3232 Arixtra 5 mg/.4ml Subcutaneous Injection, Solution by Glaxosmithkline LLC
  • 0007-3234 Arixtra 7.5 mg/.6ml Subcutaneous Injection, Solution by Glaxosmithkline LLC
  • 0007-3236 Arixtra 10 mg/.8ml Subcutaneous Injection, Solution by Glaxosmithkline LLC
  • 54868-5501 Arixtra 7.5 mg/.6ml Subcutaneous Injection, Solution by Physicians Total Care, Inc.
  • 67457-592 Arixtra 2.5 mg/.5ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-593 Arixtra 5 mg/.4ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-594 Arixtra 7.5 mg/.6ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-595 Arixtra 10 mg/.8ml Subcutaneous Injection, Solution by Mylan Institutional LLC

Other drugs which contain Fondaparinux or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA